Funding for this research was provided by:
canadian institutes of health research (TC2165734)
Received: 26 July 2021
Accepted: 15 January 2022
First Online: 7 February 2022
: Ethics approval was obtained via Clinical Trials Ontario (CTO-1932) and West Park Healthcare Centre. Written informed consent will be obtained from all participants. Child and adolescent assent will be obtained as appropriate.
: Not applicable.
: This is an investigator initiated, designed, and managed research study. Although this research is being done in collaboration with Aetonix, the company that developed and patented the aTouchAway™ virtual care platform being used for this study, the company had no role in the design of the study and will have no role in study conduct or interpretation of study results.